Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S ADR
(NY:
NVO
)
142.74
-1.75 (-1.21%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novo Nordisk A/S ADR
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
49
50
Next >
10 Health Care Stocks Whale Activity In Today's Session
January 04, 2024
Via
Benzinga
Eli Lilly Launches Website To Help Patients With Home Delivery Options For Weight Loss Medicines
January 04, 2024
Eli Lilly announced a new website allowing patients to get a weight loss drug prescription through a telehealth provider, with disease management resources, home delivery of medicines.
Via
Benzinga
Eli Lilly Beefs Up Its Weight-Loss Marketing Efforts With New Direct-To-Consumer Site
January 04, 2024
Eli Lilly will connect patients with doctors, support and direct-to-home delivery of specific medicines.
Via
Investor's Business Daily
Famed Obesity Drug Maker Novo Nordisk Inks Collaborations For Cardiometabolic Diseases
January 04, 2024
Novo Nordisk A/S (NYSE: NVO), Omega Therapeutics Inc (NASDAQ: OMGA), and Cellarity Inc.
Via
Benzinga
Novo Nordisk, The Weight-Loss Kingpin, Inks Two New Obesity Deals
January 04, 2024
Shares of one new partner nearly doubled after Novo Nordisk pledged to pay up to $532 million.
Via
Investor's Business Daily
While growth is established for NYSE:NVO, the stock's valuation remains reasonable.
January 02, 2024
NYSE:NVO is showing decent growth, but is still valued reasonably.
Via
Chartmill
Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
December 27, 2023
Via
Benzinga
(NVO) - Analyzing Novo Nordisk's Short Interest
December 25, 2023
Via
Benzinga
The Best Stocks to Invest $1,000 in Right Now
January 04, 2024
It's not too late to get in on these market beaters.
Via
The Motley Fool
Why Is Omega Therapeutics (OMGA) Stock Up 111% Today?
January 04, 2024
Omega Therapeutics stock is rising higher on Thursday as investors in OMGA react to a search collaboration agreement with Novo Nordisk.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 04, 2024
Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday!
Via
InvestorPlace
Missed Out on Eli Lilly? My Best Pharmaceutical Stock to Buy And Hold
January 03, 2024
The past three years were bliss for Eli Lilly shareholders, but those not already on board should look at its rival instead.
Via
The Motley Fool
1 Stock-Split Stock to Buy Hand Over Fist in 2024 and 1 to Avoid
January 03, 2024
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a historically cheap outperformer that's ripe for the picking, as well as an...
Via
The Motley Fool
Here's How Much $1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth Today
December 21, 2023
Via
Benzinga
3 Biotech Stocks at the Forefront of the Quest for Eternal Youth
January 02, 2024
Biotech stocks targeting longevity could uncover the fountain of youth in coming years, offering a prime investment opportunity today.
Via
InvestorPlace
New Year Resolution Stocks: Can Getting Fitter Be A Winner On The Stock Market?
January 02, 2024
Novo Nordisk's shares gained 50.7% in 2023 thanks largely to sales of its weight loss drugs, while Eli Lilly's shares have jumped 60.7%.
Via
Benzinga
2024’s Power Players: 7 Stocks Racing to a Trillion Valuation
January 01, 2024
Whether in 2024, or in the years ahead, each of these seven stocks could become the next trillion dollar companies.
Via
InvestorPlace
Prediction: These 3 Stocks Will Soar in 2024
January 01, 2024
Investors could enjoy an especially happy new year with these great stocks.
Via
The Motley Fool
3 Ken Griffin Stocks to Invest Like Citadel
December 30, 2023
Invest like Citadel founder and billionaire Ken Griffin with these stocks that have strong potential heading into 2024.
Via
InvestorPlace
These 3 Companies Can Be the Next Stock-Split Stocks in 2024
December 29, 2023
Since mid-2021, Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk have conducted stock splits. Three well-known companies look set to follow in...
Via
The Motley Fool
Meet the Stock-Split Stock Warren Buffett Is Likeliest to Buy in 2024
December 27, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a stock-split stock that checks all the right boxes for the Oracle of Omaha.
Via
The Motley Fool
3 Stock-Split Stocks Billionaires Are Piling Into Ahead of 2024
December 25, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry leaders Wall Street's brightest money managers want to own for...
Via
The Motley Fool
Novo Nordisk, Maker Of 'Miracle' Weight Loss Drug Ozempic, Announces Mega Factory In Dublin
December 24, 2023
Via
Benzinga
Will Novo Nordisk Be Worth More Than Meta Platforms by 2030?
December 23, 2023
The gap in market cap between these two companies is big today, but it could shrink in the future.
Via
The Motley Fool
Fake Ozempic - FDA and Novo Nordisk Warn Against Counterfeit Ozempic Penetrating US Market Amid High Demand
December 22, 2023
The FDA on Thursday said it continues to investigate counterfeit Novo Nordisk A/S's&n
Via
Benzinga
Exposures
Product Safety
7 Low-Volatility Stocks for Stable Growth in 2024
December 21, 2023
Wager on these stocks to buy for stable growth, handpicked for their low volatility and potential to weather economic headwinds.
Via
InvestorPlace
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
December 21, 2023
Which weight-loss stocks are good buys today?
Via
The Motley Fool
Looking to Invest in the Next Big Craze Like Ozempic? This 1 Emerging Field Could Be It.
December 21, 2023
Diabetes and weight-loss drugs won't be the hottest category of medicines forever.
Via
The Motley Fool
Why Novo Nordisk Stock Was Up on a Down Day for the Market
December 20, 2023
As if the company's top two products weren't popular enough, a new media report made them even more appealing.
Via
The Motley Fool
Weight Loss Drugs By Novo Nordisk, Eli Lilly Don't Deter Nestle's Coffee Demand - CEO Explains Why
December 20, 2023
Nestle S.A. (OTC: NSRGY) CEO Mark Schneider stated that despite the rising use of weight loss medications like Eli Lilly And Company's (NYSE: LLY) Zepbound and Novo Nordisk's
Via
Benzinga
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
49
50
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.